Patient
SITE006-0124
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE006 (GBR) (Dr. Rossi)
consented 2026-01-27
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-11-06 (study day 95); relationship: RELATED
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-09-20 (study day 48); relationship: not assessed
Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-09-11 (study day 39); relationship: not assessed
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-09-05 (study day 33); relationship: NOT RELATED
Grade 4 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-08-06 (study day 3); relationship: not assessed; serious criteria: life-threatening
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.